Dengue Testing Market to Reach USD 1.23 Billion by 2035, Growing at 6.82% CAGR
The global Dengue Testing Market is projected to reach USD 1.23 billion by 2035, driven by rising demand for early diagnosis, rapid testing technologies, point-of-care solutions, and improved healthcare infrastructure worldwide.
The global Dengue Testing Market is witnessing steady expansion as healthcare providers, diagnostic laboratories, and public health organizations increase their focus on early detection, reliable diagnosis, and improved preparedness for dengue outbreaks.
According to Quintile Reports, the global Dengue Testing Market was valued at USD 637.90 million in 2026 and is projected to reach USD 1,234.3 million by 2035, registering a CAGR of 6.82% during 2026–2035.
The growing need for timely dengue diagnosis is supporting demand for a range of diagnostic technologies. The market includes ELISA-based tests, RT-PCR tests, dengue NS1 antigen rapid tests, IgG/IgM antibody rapid tests, and other testing technologies.
Rising Demand for Rapid Diagnostics
One of the key developments influencing the market is the growing adoption of rapid diagnostic solutions. Point-of-care testing can provide healthcare professionals with faster access to diagnostic information and may be particularly valuable in locations where centralized laboratory infrastructure is limited.
The market is analyzed across Point-of-Care Testing and Laboratory Testing, providing insight into how different testing environments contribute to overall market growth.
Increasing investments in healthcare infrastructure and diagnostic capabilities are also creating opportunities for testing manufacturers across emerging markets.
Asia Pacific Offers Significant Opportunities
Asia Pacific represents an important regional market for dengue testing, supported by dengue prevalence, healthcare infrastructure development, disease awareness, and public health initiatives.
Countries covered in the Quintile Reports analysis include India, China, Japan, Australia, South Korea, and Thailand, among others.
Latin America is another important market, with countries such as Brazil, Mexico, Argentina, and Colombia included in the regional assessment. North America and Europe also contribute to the global market through advanced healthcare infrastructure and diagnostic capabilities.
Technology and Market Development
The continued development of molecular diagnostics, rapid antigen testing, antibody testing, and laboratory-based diagnostic solutions is expected to shape the competitive environment.
Manufacturers are focusing on factors such as testing speed, accessibility, usability, diagnostic performance, and cost efficiency. The expansion of point-of-care solutions could further improve access to dengue testing in underserved and remote healthcare settings.
However, the industry continues to face challenges, including the cost of advanced equipment, laboratory infrastructure requirements, availability of trained personnel, and varying regulatory requirements across countries.
Competitive Landscape
The Dengue Testing Market includes several established diagnostic and healthcare companies. The Quintile Reports study profiles companies including Abbott Laboratories, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Danaher Corporation, Quest Diagnostics Incorporated, QuidelOrtho Corporation, ARKRAY Inc., bioMérieux SA, InBios International Inc., Meridian Bioscience Inc., SD Biosensor Inc., GenBody Inc., and NovaTec Immundiagnostica GmbH.
Competition is expected to remain focused on diagnostic innovation, product development, geographic expansion, and improving access to testing technologies.
Outlook Through 2035
With the global Dengue Testing Market expected to grow from USD 637.90 million in 2026 to USD 1,234.3 million by 2035, opportunities are emerging across diagnostic technologies, testing settings, sample types, distribution channels, and regional markets.
The Quintile Reports Dengue Testing Market Research Report provides historical analysis for 2017–2024 and forecasts for 2026–2035, covering market size, growth trends, market dynamics, segmentation, regional analysis, competitive landscape, and key companies.
Read the full Dengue Testing Market Report : https://www.quintilereports.com/industry-report/1107-dengue-testing-market/
Key Highlights:
2026 Market Size: USD 637.90 Million
2035 Projected Market Size: USD 1,234.3 Million
CAGR: 6.82%
Forecast Period: 2026–2035
Base Year: 2025
About Quintile Reports: Quintile Reports provides market research and industry intelligence covering emerging markets, technologies, regional developments, competitive landscapes, and future growth opportunities.
According to Quintile Reports, the global Dengue Testing Market was valued at USD 637.90 million in 2026 and is projected to reach USD 1,234.3 million by 2035, registering a CAGR of 6.82% during 2026–2035.
The growing need for timely dengue diagnosis is supporting demand for a range of diagnostic technologies. The market includes ELISA-based tests, RT-PCR tests, dengue NS1 antigen rapid tests, IgG/IgM antibody rapid tests, and other testing technologies.
Rising Demand for Rapid Diagnostics
One of the key developments influencing the market is the growing adoption of rapid diagnostic solutions. Point-of-care testing can provide healthcare professionals with faster access to diagnostic information and may be particularly valuable in locations where centralized laboratory infrastructure is limited.
The market is analyzed across Point-of-Care Testing and Laboratory Testing, providing insight into how different testing environments contribute to overall market growth.
Increasing investments in healthcare infrastructure and diagnostic capabilities are also creating opportunities for testing manufacturers across emerging markets.
Asia Pacific Offers Significant Opportunities
Asia Pacific represents an important regional market for dengue testing, supported by dengue prevalence, healthcare infrastructure development, disease awareness, and public health initiatives.
Countries covered in the Quintile Reports analysis include India, China, Japan, Australia, South Korea, and Thailand, among others.
Latin America is another important market, with countries such as Brazil, Mexico, Argentina, and Colombia included in the regional assessment. North America and Europe also contribute to the global market through advanced healthcare infrastructure and diagnostic capabilities.
Technology and Market Development
The continued development of molecular diagnostics, rapid antigen testing, antibody testing, and laboratory-based diagnostic solutions is expected to shape the competitive environment.
Manufacturers are focusing on factors such as testing speed, accessibility, usability, diagnostic performance, and cost efficiency. The expansion of point-of-care solutions could further improve access to dengue testing in underserved and remote healthcare settings.
However, the industry continues to face challenges, including the cost of advanced equipment, laboratory infrastructure requirements, availability of trained personnel, and varying regulatory requirements across countries.
Competitive Landscape
The Dengue Testing Market includes several established diagnostic and healthcare companies. The Quintile Reports study profiles companies including Abbott Laboratories, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Siemens Healthineers, Danaher Corporation, Quest Diagnostics Incorporated, QuidelOrtho Corporation, ARKRAY Inc., bioMérieux SA, InBios International Inc., Meridian Bioscience Inc., SD Biosensor Inc., GenBody Inc., and NovaTec Immundiagnostica GmbH.
Competition is expected to remain focused on diagnostic innovation, product development, geographic expansion, and improving access to testing technologies.
Outlook Through 2035
With the global Dengue Testing Market expected to grow from USD 637.90 million in 2026 to USD 1,234.3 million by 2035, opportunities are emerging across diagnostic technologies, testing settings, sample types, distribution channels, and regional markets.
The Quintile Reports Dengue Testing Market Research Report provides historical analysis for 2017–2024 and forecasts for 2026–2035, covering market size, growth trends, market dynamics, segmentation, regional analysis, competitive landscape, and key companies.
Read the full Dengue Testing Market Report : https://www.quintilereports.com/industry-report/1107-dengue-testing-market/
Key Highlights:
2026 Market Size: USD 637.90 Million
2035 Projected Market Size: USD 1,234.3 Million
CAGR: 6.82%
Forecast Period: 2026–2035
Base Year: 2025
About Quintile Reports: Quintile Reports provides market research and industry intelligence covering emerging markets, technologies, regional developments, competitive landscapes, and future growth opportunities.
- Contact Email
- [email protected]
- Issued By
- Quintile Reports
- Phone
- 08668339034
- Business Address
- 112/1/2, Pyramid Axis, behind Croma Showroom
Veerbhadra Nagar, Baner, Pune, Maharashtra 411045 - Country
- India
- Categories
- Health
- Last Updated
- August 27, 2026